Samalin Investment Counsel’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Buy
154,616
+28,768
+23% +$567K 1.06% 24
2026
Q1
$2.24M Buy
125,848
+44,099
+54% +$834K 0.79% 30
2025
Q4
$1.55M Sell
81,749
-10,537
-11% -$199K 0.55% 39
2025
Q3
$1.7M Buy
92,286
+4,436
+5% +$72.5K 0.59% 34
2025
Q2
$1.36M Buy
87,850
+7,802
+10% +$121K 0.52% 42
2025
Q1
$1.3M Buy
80,048
+7,204
+10% +$124K 0.53% 42
2024
Q4
$1.17M Buy
72,844
+4,875
+7% +$86.5K 0.5% 44
2024
Q3
$1.27M Buy
67,969
+685
+1% +$12.8K 0.55% 42
2024
Q2
$1.17M Buy
67,284
+7,803
+13% +$130K 0.55% 42
2024
Q1
$1M Buy
59,481
+4,436
+8% +$75.6K 0.48% 56
2023
Q4
$912K Buy
55,045
+11,354
+26% +$175K 0.46% 56
2023
Q3
$679K Buy
43,691
+15,281
+54% +$255K 0.39% 77
2023
Q2
$484K Buy
28,410
+8,002
+39% +$139K 0.26% 117
2023
Q1
$360K Buy
+20,408
New +$371K 0.22% 136

Other funds holding HQH

Samalin Investment Counsel's HQH Position: Q2 2026 in Review

Samalin Investment Counsel increased its abrdn Healthcare Investors (HQH) stake by 23% in Q2 2026, buying an estimated $567K and bringing the position to 154,616 shares worth $3.4M. The position accounts for 1.06% of the portfolio, ranked #24.

Samalin Investment Counsel first reported a position in HQH in Q1 2023 and has held it in 14 quarters since. 46 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Samalin Investment Counsel held 154,616 shares of abrdn Healthcare Investors worth $3.4M as of Q2 2026.
  • Samalin Investment Counsel bought 28,768 abrdn Healthcare Investors shares in Q2 2026, an estimated $567K.
  • abrdn Healthcare Investors made up 1.06% of Samalin Investment Counsel's portfolio in Q2 2026, its #24 holding.
  • Samalin Investment Counsel first reported a position in abrdn Healthcare Investors in Q1 2023 and has held it in 14 quarters since.
  • 46 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.